Executive Summary

  • Biosimilars are biological medicines which replicate a branded biological medicine, in a similar fashion to generics with conventional chemical pharmaceuticals
  • Due to their biological nature, biosimilars are only very similar, rather than being identical to the original product as with generics
  • Biosimilars are not typically assessed by HTAs, but equally cannot be considered to be interchangable with the original biological therapeutic